Business steps in: Companies are also taking note of the potential for plasma.
Adam Schechter, CEO of testing firm LabCorp, said at the Red Cross roundtable that his company will offer free antibody testing through doctor’s offices to increase blood plasma donations. “LabCorp is currently working with public health authorities and the provider community on the details of the three-month program and will provide additional information in the near future,” the company said in a statement.
Paul Perreault, CEO of CSL Limited, said his company and NIH are designing A clinical trial to test a treatment known as immune immune globulin, which is derived from convalescent plasma. The company is enrolling patients in the trial next month. If it proves the treatment is effective, CSL could file an application with the FDA by the end of this year, Perreault said.
What̵7;s next: Hahn said the agency is reviewing the data behind the effectiveness of convalescent plasma. Clinical trials are ongoing and emergency authorization by the FDA to expand plasma use may be forthcoming.